Guangzhou Kingmed Diagnostics Group Co., Ltd.

SHSE:603882 Stock Report

Market Cap: CN¥12.1b

Guangzhou Kingmed Diagnostics Group Future Growth

Future criteria checks 4/6

Guangzhou Kingmed Diagnostics Group is forecast to grow earnings and revenue by 34.9% and 13.9% per annum respectively. EPS is expected to grow by 33.7% per annum. Return on equity is forecast to be 11.9% in 3 years.

Key information

34.9%

Earnings growth rate

33.7%

EPS growth rate

Healthcare earnings growth21.9%
Revenue growth rate13.9%
Future return on equity11.9%
Analyst coverage

Good

Last updated16 Jul 2024

Recent future growth updates

Recent updates

Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

Aug 25
Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Jun 04
A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings

May 02
Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings

Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%

Apr 17
Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%

Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking

Feb 28
Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking

Earnings and Revenue Growth Forecasts

SHSE:603882 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202612,0001,2711,4531,7769
12/31/202510,6841,0434661,62711
12/31/20249,083660-581,95210
3/31/20248,263475195873N/A
12/31/20238,5406435161,231N/A
9/30/20239,5788823421,126N/A
6/30/202311,4721,3977291,448N/A
3/31/202313,3422,0541,3252,077N/A
12/31/202215,4762,7551,1071,948N/A
9/30/202215,5342,9961,4632,352N/A
6/30/202214,8002,8031,3492,325N/A
3/31/202213,5162,5321,0182,018N/A
12/31/202111,9432,2201,1362,088N/A
9/30/202111,0342,1277871,646N/A
6/30/202110,2252,0131,1761,900N/A
3/31/20219,7522,0001,1761,802N/A
12/31/20208,2441,5109721,523N/A
9/30/20207,1761,1388071,240N/A
6/30/20206,201787383745N/A
3/31/20205,276408236555N/A
12/31/20195,269402386661N/A
9/30/20195,128388323635N/A
6/30/20194,954309254571N/A
3/31/20194,771266226558N/A
12/31/20184,525233183530N/A
9/30/20184,30920551384N/A
6/30/20184,1072007340N/A
3/31/20183,909191-95289N/A
12/31/20173,792189N/A284N/A
9/30/20173,689198N/A292N/A
12/31/20163,222170N/A292N/A
9/30/20163,010153N/A253N/A
12/31/20152,389140N/A220N/A
12/31/20141,83871N/A226N/A
12/31/20131,35652N/A76N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603882's forecast earnings growth (34.9% per year) is above the savings rate (2.9%).

Earnings vs Market: 603882's earnings (34.9% per year) are forecast to grow faster than the CN market (22% per year).

High Growth Earnings: 603882's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 603882's revenue (13.9% per year) is forecast to grow faster than the CN market (13.4% per year).

High Growth Revenue: 603882's revenue (13.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 603882's Return on Equity is forecast to be low in 3 years time (11.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y